What happened
iNtRON Biotechnology disclosed convertible bonds to raise US$1.94M, about 3.4% of its market value.
For context, this raise equals about 3.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$1.94M |
| vs. market value | 3.4% |
| Filed | 2026-06-30, Material event report (convertible bonds) |
| Source | DART rcept 20260630000749 → open original filing |
Source: DART. Information only, not investment advice.